By Jacinta R. Wiens, Ph.D., M.S., Director, Lung Cancer Registry, GO2 for Lung Cancer

The Lung Cancer Registry (LCR), created by the GO2 for Lung Cancer, is a global online database that was launched in 2016. The LCR was designed so that patients could contribute their individual experiences with lung cancer through survey questions asking about the patient, their medical history and diagnosis, treatment, outcomes, and quality of life. The information provided is completely secure; the user decides who sees the information, how it will be used and if they want to be contacted by researchers. Whether you have been diagnosed with lung cancer or have provided care for someone with lung cancer, your contributions are meaningful. By joining our growing registry, represented by over 2,300 members in more than 40 countries and 6 continents across the world, you are giving researchers access to crucial data that will help make new discoveries. микрозаймы онлайн где взять

Global Distribution of Lung Cancer Registry Members

Lung Cancer Registry Studies

Lung Cancer Patient Study

The lung cancer patient study is an ongoing international study that consists of a baseline (upon registration) and quarterly longitudinal surveys to understand the lung cancer patient experience. The questionnaires ask about the patient’s background, overall health, lung cancer diagnosis, treatment history, treatment satisfaction and side-effects, patient quality of life and outcomes. Researchers  can look for patterns in the data collected that will improve patient care and treatment.

Who can participate? Patients over the age of 18 years of age diagnosed with lung cancer or a caregiver of a person that has been diagnosed with lung cancer.

Expected time to complete: 20-30 minutes

COVID-19

The COVID-19 survey is an ongoing international study consisting of a short questionnaire aimed at better understanding how lung cancer patient care, treatments and outcomes have been affected by COVID-19.

Who can participate? Patients over the age of 18 years of age diagnosed with lung cancer or a caregiver of a person that has been diagnosed with lung cancer.

Estimated time to complete: 5-10 minutes

Sexual Health Assessment in Women with Lung Cancer (SHAWL).

SHAWL is a landmark international research study aimed at assessing sexual dysfunction in women with lung cancer. This study is a partnership between the Lung Cancer Registry and Dr. Narjust Duma at University of Wisconsin.

Who can participate? Any woman over the age of 18 years of age who has been diagnosed with lung cancer.

Expected time to complete: 10-15 minutes

To participate in one of our studies simply join the Lung Cancer Registry at www.lungcancerregistry.org.

No one understands lung cancer like those who live with it every day. Join us today!

Already a member? You will be contacted as new studies become available.

Questions? Learn more by contacting registry@go2.org.